Lobbying

International Rett Syndrome Foundation's latest lobbying report covers Q3 2025, at under $5,000. Its first report covers Q1 2024; the issues it reports most are Budget/Appropriations and Medical/Disease Research/Clinical Labs.

International Rett Syndrome Foundation

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2024
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

International Rett Syndrome Foundation lobbying by quarter
International Rett Syndrome Foundation lobbying by quarter
QuarterAmountReports
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Budget and appropriations$0 · 7 reports
  • Medical research and clinical labs$0 · 7 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES7 reports
  • SENATE7 reports

Firms it paid

Firm
The Conafay Group$07 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
25/10/20for Q3 2025The Conafay GroupUnder $5,000
25/07/18for Q2 2025The Conafay GroupUnder $5,000
25/04/18for Q1 2025The Conafay GroupUnder $5,000
25/01/17for Q4 2024The Conafay GroupUnder $5,000
24/10/18for Q3 2024The Conafay GroupUnder $5,000
24/07/19for Q2 2024The Conafay GroupUnder $5,000
24/04/19for Q1 2024The Conafay GroupUnder $5,000
24/03/08for Q1 2024The Conafay GroupUnder $5,000